Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
MONDAY, Oct. 19, 2020 -- Most users report taking cannabidiol (CBD) as a therapeutic for diagnosable health conditions, according to a case series published online Oct. 15 in JAMA Network Open.
Eric C. Leas, Ph.D., M.P.H., from the Qualcomm Institute at the University of California in San Diego, and colleagues assessed the reasons why individuals are using CBD. The analysis included treatment applications reported by 376 randomly selected CBD users in public testimonials shared on the Reddit forum r/CBD.
The researchers found that 90.0 percent of testimonials claimed that CBD treated the individual's diagnosable conditions. The most frequently cited subcategory included psychiatric conditions (e.g., autism or depression; 63.9 percent), followed by orthopedic (26.4 percent), sleep (14.6 percent), and neurological (6.9 percent) conditions. Testimonials less frequently claimed that CBD treated gastroenterological conditions (3.9 percent), as well as addiction, cardiological, dermatological, ophthalmological, oral health, and sexual health conditions (<2.0 percent each). Less than one-third of testimonials (29.5 percent) claimed any wellness benefit, with nearly all citing mental wellness (e.g., "quieting my mind").
"The findings of this case series suggest a need for regulation of factors associated with CBD being used to treat diagnosable conditions, engagement of health care professionals with patients on their potential CBD use, and implementation of public health campaigns that encourage the public to seek treatment advice from health care professionals regarding evidence-based therapies," the authors write.
© 2020 HealthDay. All rights reserved.
Posted: October 2020
Read this next
FRIDAY, Nov. 20, 2020 -- Office-based visits for behavioral and psychiatric conditions decreased in association with the COVID-19 pandemic, although increases in telemedicine...
FRIDAY, Nov. 20, 2020 -- Even modest depression, anxiety, and catastrophizing are predictors of whether a patient later experiences improvements in pain relief following joint...
THURSDAY, Nov. 19, 2020 -- Job insecurity as a result of the COVID-19 pandemic is associated with self-reported anxiety and depression among U.S. young adults, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.